UChicago Medicine AdventHealth Cancer Institute Hinsdale — Hinsdale, Illinois

UChicago Medicine AdventHealth Cancer Institute Hinsdale is a clinical research site located in Hinsdale, Illinois, United States 60521.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

UChicago Medicine AdventHealth Cancer Institute Hinsdale has participated in 12 clinical trials with 9 currently active.

Therapeutic areas: Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, FIGO Stage III Ovarian Cancer 2014.

Sponsors: NRG Oncology, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hinsdale

Browse all research sites in Illinois · View every site in Hinsdale

• University of Illinois Health/ University of Illinois at Chicago
• RML Specialty Hospital
• Adventist Hinsdale Hospital
• Rush University Medical Center
• Hinsdale Hospital
• University of Chicago
• Illinois Heart and Vascular at Adventist Hinsdale Hospital
• Adventist Hospital
• Hinsdale Hematology Oncology Associates
• Sudarshan K Sharma MD Limited-Gynecologic Oncology
• Hope and Healing Cancer Services
• Sudarshan K Sharma MD Limted-Gynecologic Oncology

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UChicago Medicine AdventHealth Cancer Institute Hinsdale?

UChicago Medicine AdventHealth Cancer Institute Hinsdale has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UChicago Medicine AdventHealth Cancer Institute Hinsdale conducted?

UChicago Medicine AdventHealth Cancer Institute Hinsdale has 12 clinical trials on record, with 9 currently active. Their work covers Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, FIGO Stage III Ovarian Cancer 2014.

Is UChicago Medicine AdventHealth Cancer Institute Hinsdale accredited by Crixeo Clinical Trials?

UChicago Medicine AdventHealth Cancer Institute Hinsdale has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UChicago Medicine AdventHealth Cancer Institute Hinsdale?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.